BioFinland Member

Admescope is a contract research organisation (CRO) providing tailor made ADME-Tox services to drug discovery and development companies all around the world.

The service offering is widely spread over the whole ADME-Tox area with top-notch expertise in drug metabolism, drug-drug interactions, pharmacokinetics and quantitative bioanalysis. The right assays always available, whether in the discovery, lead optimisation or preclinical development phase. The level of data interpretation can be customised according to customer preferences.Our services are available for all drug modalities, e.g., small molecules, peptides, oligonucleotides, antibodies and ADCs. Admescope is part of Symeres, with the ability to provide medicinal chemistry and integrated drug discovery & development services through the Symeres organization.

Admescope Service Offering:

- In vitro Metabolism
- In vivo DMPK
- Drug Interactions
- Quantitative Bioanalysis
- Permeability and Transporters
- Physicochemistry and Binding
- In vitro Toxicology
- Biologics